Viking Therapeutics' leading candidate posted strong mid-stage data and is undergoing phase 3 studies. Though there are some risks, the stock could soar if it can pass the upcoming clinical and ...

Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% revenue growth in 2026 following the launch of its next-generation Covid vaccine ...

Moderna’s messenger RNA influenza vaccine succeeded in two pivotal clinical trials, but the Food and Drug Administration is refusing to even review the application seeking regulatory approval, telling ...

Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot. Reading time 3 minutes The federal government’s crusade against ...

We may receive a commission on purchases made from links. Target is one of the biggest retailers in the United States. It owns more than 40 brands, and around one-third of all the products it sells ...

Flu activity is widespread and severe in Georgia, and cases are likely to increase following the holidays and as Georgians return to work and school. The Centers for Disease Control and Prevention ...